Consultant

Prof Naila Arebi

Consultant Gastroenterologist
MD, MSc, PhD, FRCP
naila_arebi.jpg

Professor Arebi is a consultant gastroenterologist with an interest in inflammatory bowel disease. She leads the IBD Service at St Mark's National Bowel Hospital and won awards for quality improvement initiatives. She is an elected member of the European Crohn's and Colitis organisation and the British Society of Gastroenterology.

Gastroenterology
English
In-person, Phone call, Video call
New £300 (follow-up £200)

Bio

Professor Arebi qualified as a doctor in Malta and completed her higher training in the UK. She is a key opinion leader in her field of Inflammatory Bowel Disease (IBD). She leads the IBD Service at St Mark's National Bowel Hospital and won awards for quality improvement initiatives.

She is an elected member of the European Crohn's and Colitis organisation and the British Society of Gastroenterology. She has an active research portfolio in quality improvement, epidemiology and novel treatment approached to IBD.

Professor Naila Arebi is a keen cyclist.

More information

116 Harley Street
London W1G 7JL

Dr Naila Arebi is available through The London Clinic's Connect service for video consultations.

Book a video consultation

  • Consultant Gastroenterologist
    St Mark's National Bowel Hospital
  • Honorary Senior Lecturer
    Imperial College, London
  • Assessment and investigation of intestinal symptoms including diarrhoea, constipation, rectal bleeding, weight loss, heartburn
  • Assessment and management of ulcerative colitis and crohn’s disease
  • Investigations for heartburn and reflux with bravo pH capsule
  • Year qualified 1989
  • Malta Medical School 1989

Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project

Year: 2019
BMJ Open Qual

Surgery versus infliximab for Crohn's disease: should there be a change in clinical practice?

Year: 2020
Lancet Gatroenterol Hepatol

Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study

Year: 2019
World J Gastroenterol

A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence

Year: 2022
Published by: Journal of Crohn's and Colitis 
Authors: Wong, C van Oostrom, J Bossuyt, P Pittet, V Hanzel, J Samaan, M Tripathi, M Czuber-Dochan, W Burisch, J Leone, S Saldana, R Baert, F Kopylov, U Jaghult, S Adamina, M Gecse, K Arebi, N

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

Year: 2022
Published by: Lancet Gastroenterology and Hepatology
Authors: Papamichael, Konstantinos Afif, Waqqas Drobne, David Dubinsky, Marla C. Ferrante, Marc Irving, Peter M. Kamperidis, Nikolaos Kobayashi, Taku Kotze, Paulo G. Lambert, Jo Noor, Nurulamin M. Roblin, Xavier Roda, Giulia Vande Casteele, Niels Yarur, Andres J. Arebi, Naila Danese, Silvio Paul, Stephane Sandborn, William J. Vermeire, Severine Cheifetz, Adam S. Peyrin-Biroulet, Laurent

Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease

Year: 2022
Published by: Gastroenterology
Authors: ariente, B Torres, J Burisch, J Arebi, N Barberio, B Duricova, D Ellul, P Goldis, A Kaimakliotis, I Katsanos, K Krznaric, Z McNamara, D Pedersen, N Sebastian, S Azahaf, M Weimers, P Lung, P Lacognata, C Horak, M Christodoulou, D Domislovic, V Murphy, I Lambert, J Ungaro, R Colombel, JF

  • BMJ commended award for IBD services
  • Brian Turley Award for IBD services and patient partnerships
  • NHS Clinical Excellence Awards

Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.